1800-121-1711 
Donate 
Book an Appointment
Quick Enquiry
.png)
Acute Myeloid Leukemia (AML) is a type of cancer that affects the bone marrow and blood, characterized by the rapid growth of abnormal myeloid cell...
Acute Myeloid Leukemia (AML) is a type of cancer that affects the bone marrow and blood, characterized by the rapid growth of abnormal myeloid cells. This condition typically progresses quickly and requires immediate treatment. While the exact cause of AML is often unknown, certain risk factors may increase its likelihood, including exposure to radiation or certain chemicals, previous chemotherapy or radiation therapy for other cancers, certain genetic disorders such as Down syndrome, and a history of certain blood disorders. Symptoms of AML may include fatigue, weakness, pale skin, frequent infections, easy bruising or bleeding, shortness of breath, and unexplained weight loss. Diagnosing AML typically involves a combination of blood tests, bone marrow aspiration, and imaging studies to confirm the presence of abnormal cells and determine the subtype of the disease. Treatment options for AML depend on factors such as the patient's age, overall health, and subtype of the disease. Options may include chemotherapy, targeted therapy, radiation therapy, stem cell transplantation, or a combination of these approaches. Supportive care and close monitoring are essential components of treatment, aiming to manage symptoms, prevent complications, and support the patient's overall well-being. While the prognosis for AML can vary depending on several factors, ongoing research and advancements in treatment offer hope for improved outcomes and quality of life for individuals affected by this challenging disease.
Facing a cancer diagnosis can be overwhelming. Our brief guide offers insights into various types of cancer, detailing symptoms, detection, treatments, and post-treatment care, providing support and clarity along your journey.
Risk factors for acute myeloid leukemia (AML) include exposure to certain chemicals such as benzene, previous chemotherapy or radiation therapy for other cancers, certain genetic disorders such as Down syndrome and Fanconi anemia, older age, smoking, and a history of certain blood disorders. While these factors may increase the risk, the majority of cases of AML occur sporadically without any identifiable risk factors.
Signs and symptoms of acute myeloid leukemia may include fatigue, weakness, pale skin, frequent infections, easy bruising or bleeding, shortness of breath, fever, and unexplained weight loss. These symptoms often result from the overproduction of abnormal myeloid cells crowding out normal blood cells in the bone marrow.
Diagnosing acute myeloid leukemia typically involves a combination of blood tests, bone marrow aspiration, and imaging studies. Blood tests may reveal abnormal levels of white blood cells, red blood cells, and platelets, while bone marrow aspiration allows for the examination of the bone marrow cells to confirm the presence of leukemia cells.
Treatment for acute myeloid leukemia depends on factors such as the patient's age, overall health, and subtype of the disease. Options may include chemotherapy, targeted therapy, radiation therapy, stem cell transplantation, or a combination of these approaches. The goal of treatment is to induce remission, eliminate cancer cells, and prevent relapse.
Supportive care and rehabilitation are essential components of treatment for acute myeloid leukemia, aiming to manage symptoms, prevent complications, and support the patient's overall well-being. This may include medications to manage pain and side effects of treatment, nutritional support, psychological counseling, and physical therapy.
Preventing acute myeloid leukemia may not be entirely possible due to its complex nature and often unknown causes. However, avoiding exposure to known risk factors such as chemicals and radiation, maintaining a healthy lifestyle, and avoiding harmful behaviors such as smoking can contribute to overall health and well-being.
Acute myeloid leukemia is a serious and often aggressive disease that requires prompt diagnosis and comprehensive treatment. While the prognosis for AML can vary depending on several factors, ongoing research and advancements in treatment offer hope for improved outcomes and quality of life for individuals affected by this challenging disease. By understanding the risk factors, recognizing the signs and symptoms, and seeking timely medical care, individuals can take proactive steps to address this disease and improve their chances of successful treatment and long-term survival.
Acute Myeloid Leukemia is a Cancer of the Blood and Bone Marrow characterized by the rapid growth of abnormal Myeloid Cells, which are immature White Blood Cells. These cells crowd out normal blood cells, leading to symptoms such as Fatigue, Infections, and easy bruising or bleeding.
Symptoms may vary but commonly include Fatigue, Weakness, Pale Skin, Fever, frequent Infections, easy Bruising or Bleeding, Bone Pain, Swollen Lymph Nodes, and abdominal discomfort.
Diagnosis typically involves blood tests to evaluate blood cell counts and Morphology, Bone Marrow aspiration and Biopsy to examine the marrow for Leukemia Cells, and additional tests such as flow Cytometry, Cytogenetic analysis, and molecular testing to determine the subtype and genetic characteristics of the Leukemia.
Treatment options may include Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, and Supportive Care Services. The choice of treatment depends on factors such as the subtype, genetic characteristics, and risk factors associated with the leukemia, as well as the patient's age and overall health.
Stem Cell Transplantation may be recommended for certain patients with high-risk AML or those who have relapsed after initial treatment. It involves replacing diseased Bone Marrow with healthy stem cells from a compatible donor, which can help restore normal blood cell production.
Treatment for AML may carry risks such as Infections, Bleeding, Chemotherapy-related side effects (such as Nausea, Hair Loss, and Fatigue), Organ Toxicity, and complications associated with stem cell transplantation. Your healthcare team will discuss these risks with you before starting treatment.
With advances in treatment, many patients with AML can achieve remission and long-term survival. However, the prognosis depends on factors such as the subtype and genetic characteristics of the Leukemia, the patient's age and overall health, and their response to treatment.
Targeted Therapies are medications that specifically target certain molecules or pathways involved in the growth and survival of Leukemia cells. They may be used alone or in combination with Chemotherapy to improve treatment outcomes and reduce side effects.
Yes, Clinical Trials are conducted to evaluate new treatments, combination Therapies, and Supportive Care approaches for AML. Eligible patients may have the opportunity to participate in clinical trials, gaining access to innovative Therapies while contributing to the advancement of medical science.
Offer emotional support, accompany them to appointments, assist with daily tasks, provide distractions, encourage self-care, and respect their decisions.
To schedule a consultation, please contact BMCHRC's Hematology-Oncology Department. Our team of specialists is dedicated to providing personalized care and support to patients with AML, guiding them through every step of their treatment journey.
Some patients may find relief from symptoms through complementary Therapies such as Acupuncture, Massage Therapy, relaxation techniques, or nutritional support. It's essential to discuss these options with your healthcare provider to ensure they complement your primary treatment plan.
Yes, AML can recur even after successful treatment. Regular follow-up appointments and surveillance tests are essential to monitor for any signs of recurrence.
The prognosis for AML patients depends on factors such as the subtype and genetic characteristics of the Leukemia, the patient's age and overall health, and their response to treatment. Survival rates vary widely depending on these factors.
While there are no guaranteed ways to prevent AML, maintaining a healthy lifestyle, avoiding exposure to environmental carcinogens (such as Tobacco smoke and certain chemicals), and protecting against known risk factors (such as radiation exposure) may help reduce the risk. Regular exercise, a balanced diet, and maintaining a healthy weight are also recommended.
Every contribution is a vital step forward in our battle against cancer, bringing hope and healing to countless lives. Join us in making a difference today.
Donate Now
